Ads
related to: diabetic retinopathy monitoring and treatment programfacedownsolutions.com has been visited by 10K+ users in the past month
retinalphysician.com has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
Diabetic retinopathy (also known as diabetic eye disease) is a medical condition in which damage occurs to the retina due to diabetes.It is a leading cause of blindness in developed countries and one of the lead causes of sight loss in the world, even though there are many new therapies and improved treatments for helping people live with diabetes.
Diabetic Retinopathy Study: This study evaluated whether treatment with either an argon laser or xenon arc lamp could prevent severe vision loss caused by diabetic retinopathy. It showed that this type of treatment effectively reduced the risk of severe vision loss, especially in patients at higher risk.
Diabetic retinopathy is a leading cause of blindness. Helen Keller International helps prepare health care systems to identify and treat diabetic retinopathy. In collaboration with Chittagong Eye Infirmary and Training Complex and the Diabetes Association of Bangladesh, Helen Keller began a pilot project in 2009 to improve patients' access to sight-saving diabetic retinopathy treatment ...
Diabetic retinopathy control (training health personnel, information media). Onchocerciasis control: continuing under the auspices of the national programmes, where the actions of the agents, extending the initial training provided by the OPC, allows approximately 1.4 million people to be protected.
Intraretinal microvascular abnormalities (IRMA) are abnormalities of the blood vessels that supply the retina of the eye, a sign of diabetic retinopathy. [1] IRMA can be difficult to distinguish from and is likely a precursor to retinal neovascularization. One way to distinguish IRMA from retinal neovascularization is to perform fluorescein ...
The American Academy of Ophthalmology practice guidelines recommend laser coagulation for people who have both mild to moderate nonproliferative diabetic retinopathy (NPDR) and clinically significant macular edema outside the fovea; treatment with anti-VEGF drugs is better than laser coagulation for clinically significant macular edema in the fovea. [1]
Ads
related to: diabetic retinopathy monitoring and treatment programfacedownsolutions.com has been visited by 10K+ users in the past month
retinalphysician.com has been visited by 10K+ users in the past month